Global Information
회사소개 | 문의 | 비교리스트

세계의 차세대 시퀀싱 시장 : 제품별, 기술별, 최종사용자별, 용도별, 지역별 경쟁, 예측, 기회(2025년)

Global Next-generation Sequencing Market By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934809
페이지 정보 영문 118 Pages
가격
US $ 4,450 ₩ 5,088,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,231,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,805,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 차세대 시퀀싱 시장 : 제품별, 기술별, 최종사용자별, 용도별, 지역별 경쟁, 예측, 기회(2025년) Global Next-generation Sequencing Market By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 118 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 차세대 시퀀싱(Next-generation Sequencing) 시장을 조사했으며, 각 지역 시장 전망, 시장 역학, 주요 동향, 경쟁 상황과 기업 개요 등의 정보를 제공하고, 전략적 제안을 제시하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 차세대 시퀀싱(NGS) 시장 전망

  • 시장 최종사용자와 예측
  • 시장 점유율과 예측
    • 제품별(소모품, 플랫폼, 서비스)
    • 기술별(합성을 통한 시퀀싱, 이온 반도체 시퀀싱, 결찰을 통한 시퀀싱, 파이로시퀀싱, 단일 분자 실시간 시퀀싱, 기타 기술)
    • 최종사용자별(학술 및 임상 조사 센터, 제약 및 바이오테크놀러지 기업, 병원 및 진료소 등)
    • 용도별(바이오마커 및 암, 진단, 생식에 관한 건강, 맞춤형 의료, 농업 및 동물 조사, 기타 용도)
    • 지역별
    • 기업별(2019년)

제6장 북미의 차세대 시퀀싱(NGS) 시장 전망

  • 시장 최종사용자와 예측
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 최종사용자별
    • 용도별
    • 국가별(미국, 캐나다, 멕시코, 기타 북미)
  • 북미 : 국가별 분석
    • 미국의 차세대 시퀀싱(NGS) 시장 전망
    • 캐나다의 차세대 시퀀싱(NGS) 시장 전망
    • 멕시코의 차세대 시퀀싱(NGS) 시장 전망

제7장 유럽의 차세대 시퀀싱(NGS) 시장 전망

  • 시장 최종사용자와 예측
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 최종사용자별
    • 용도별
    • 국가별(프랑스, 독일, 영국, 이탈리아, 스페인, 기타 유럽)
  • 유럽 : 국가별 분석
    • 프랑스의 차세대 시퀀싱(NGS) 시장 전망
    • 독일의 차세대 시퀀싱(NGS) 시장 전망
    • 영국의 차세대 시퀀싱(NGS) 시장 전망
    • 이탈리아의 차세대 시퀀싱(NGS) 시장 전망
    • 스페인의 차세대 시퀀싱(NGS) 시장 전망

제8장 아시아태평양의 차세대 시퀀싱(NGS) 시장 전망

  • 시장 최종사용자와 예측
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 최종사용자별
    • 용도별
    • 국가별(중국, 인도, 일본, 한국, 호주, 기타 아시아태평양)
  • 아시아태평양 : 국가별 분석
    • 중국의 차세대 시퀀싱(NGS) 시장 전망
    • 인도의 차세대 시퀀싱(NGS) 시장 전망
    • 일본의 차세대 시퀀싱(NGS) 시장 전망
    • 한국의 차세대 시퀀싱(NGS) 시장 전망
    • 호주의 차세대 시퀀싱(NGS) 시장 전망

제9장 중동과 아프리카의 차세대 시퀀싱(NGS) 시장 전망

  • 시장 최종사용자와 예측
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 최종사용자별
    • 용도별
    • 국가별(UAE, 사우디아라비아, 남아프리카공화국, 기타 중동 및 아프리카)
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국의 차세대 시퀀싱(NGS) 시장 전망
    • 사우디아라비아의 차세대 시퀀싱(NGS) 시장 전망
    • UAE의 차세대 시퀀싱(NGS) 시장 전망

제10장 남미의 차세대 시퀀싱(NGS) 시장 전망

  • 시장 최종사용자와 예측
  • 시장 점유율과 예측
    • 제품별
    • 기술별
    • 최종사용자별
    • 용도별
    • 국가별(브라질, 아르헨티나, 콜롬비아, 기타 남미)
  • 남미 : 국가별 분석
    • 브라질의 차세대 시퀀싱(NGS) 시장 전망
    • 아르헨티나의 차세대 시퀀싱(NGS) 시장 전망
    • 콜롬비아의 차세대 시퀀싱(NGS) 시장 전망

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향

제13장 경쟁 상황(NGS 플랫폼 프로바이더)

  • 경쟁 전망
  • 기업 개요
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • BGI Group
    • Perkinelmer
    • Agilent Technologies, Inc.
    • Qiagen N.V.
    • F. Hoffmann-La Roche AG
    • 10x Genomics
    • Oxford Nanopore Technologies
    • Takara Bio

제14장 전략적 제안

제15장 면책사항

KSM 20.06.03

Global next-generation sequencing market is projected to grow at a CAGR of close to 20% to reach USD24 billion during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of global next-generation sequencing market over the coming years. However, some of the factors that might act as major impediments to the growth of global next-generation sequencing market includes concerns pertaining to the standards of NGS based diagnostics.

The global next-generation sequencing market is segmented based on product, technology, end user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina's systems as it uses the SBS technology.

Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche AG, 10x Genomics, Oxford Nanopore Technologies, Takara Bio and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global next-generation sequencing market.
  • To classify and forecast global next-generation sequencing market based on product, technology, end user, application, company and regional distribution.
  • To identify drivers and challenges for global next-generation sequencing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global next-generation sequencing market.
  • To conduct pricing analysis for global next-generation sequencing market.
  • To identify and analyse the profile of leading players operating in global next-generation sequencing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new services, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global next-generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Next-generation sequencing service providers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to next-generation sequencing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global next-generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product:

Consumables

Platforms

Services

  • Market, By Technology:

Sequencing by Synthesis

Ion Semiconductor Sequencing

Sequencing by Ligation

Pyrosequencing

Single Molecule Real Time Sequencing

Other Technologies

  • Market, By End User:

Academic & Clinical Research Centers

Pharmaceutical & Biotechnology Companies

Hospitals & Clinics

Others

  • Market, By Application:

Biomarkers & Cancer

Diagnostics

Reproductive Health

Personalized Medicine

Agriculture & Animal Research

Other Applications

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • UAE
  • Saudi Arabia

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Next-generation Sequencing (NGS) Market Outlook

  • 5.1. Market End User & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Platforms and Services)
      • 5.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
      • 5.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
      • 5.2.1.3. By Services (Sequencing Services and Data management services)
    • 5.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies)
    • 5.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
    • 5.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications)
    • 5.2.5. By Region
    • 5.2.6. By Company (2019)
      • 5.2.6.1. By NGS Platform

6. North America Next-generation Sequencing (NGS) Market Outlook

  • 6.1. Market End User & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Application
    • 6.2.5. By Country (United States; Canada; Mexico and Rest of North America)
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next-generation Sequencing (NGS) Market Outlook
      • 6.3.1.1. Market End User & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Next-generation Sequencing (NGS) Market Outlook
      • 6.3.2.1. Market End User & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Next-generation Sequencing (NGS) Market Outlook
      • 6.3.3.1. Market End User & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application

7. Europe Next-generation Sequencing (NGS) Market Outlook

  • 7.1. Market End User & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Application
    • 7.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next-generation Sequencing (NGS) Market Outlook
      • 7.3.1.1. Market End User & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Next-generation Sequencing (NGS) Market Outlook
      • 7.3.2.1. Market End User & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Next-generation Sequencing (NGS) Market Outlook
      • 7.3.3.1. Market End User & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Next-generation Sequencing (NGS) Market Outlook
      • 7.3.4.1. Market End User & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Next-generation Sequencing (NGS) Market Outlook
      • 7.3.5.1. Market End User & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application

8. Asia-Pacific Next-generation Sequencing (NGS) Market Outlook

  • 8.1. Market End User & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Application
    • 8.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next-generation Sequencing (NGS) Market Outlook
      • 8.3.1.1. Market End User & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. India Next-generation Sequencing (NGS) Market Outlook
      • 8.3.2.1. Market End User & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Next-generation Sequencing (NGS) Market Outlook
      • 8.3.3.1. Market End User & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Next-generation Sequencing (NGS) Market Outlook
      • 8.3.4.1. Market End User & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Next-generation Sequencing (NGS) Market Outlook
      • 8.3.5.1. Market End User & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Middle East and Africa Next-generation Sequencing (NGS) Market Outlook

  • 9.1. Market End User & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Application
    • 9.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Next-generation Sequencing (NGS) Market Outlook
      • 9.3.1.1. Market End User & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Next-generation Sequencing (NGS) Market Outlook
      • 9.3.2.1. Market End User & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Next-generation Sequencing (NGS) Market Outlook
      • 9.3.3.1. Market End User & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application

10. South America Next-generation Sequencing (NGS) Market Outlook

  • 10.1. Market End User & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Application
    • 10.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Next-generation Sequencing (NGS) Market Outlook
      • 10.3.1.1. Market End User & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Argentina Next-generation Sequencing (NGS) Market Outlook
      • 10.3.2.1. Market End User & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. Colombia Next-generation Sequencing (NGS) Market Outlook
      • 10.3.3.1. Market End User & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape (NGS Platform Providers)

  • 13.1. Competition Outlook
  • 13.2. Company Profiles
    • 13.2.1. Illumina, Inc.
    • 13.2.2. Thermo Fisher Scientific, Inc
    • 13.2.3. BGI Group
    • 13.2.4. Perkinelmer
    • 13.2.5. Agilent Technologies, Inc.
    • 13.2.6. Qiagen N.V.
    • 13.2.7. F. Hoffmann-La Roche AG
    • 13.2.8. 10x Genomics
    • 13.2.9. Oxford Nanopore Technologies
    • 13.2.10. Takara Bio

14. Strategic Recommendations

15. About Us & Disclaimer

(Note: The companies list can be customized based on the client requirements.)

Back to Top
전화 문의
F A Q